CATALOGO DEI PRODOTTI DELLA RICERCA

PIGHI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.781
EU - Europa 2.349
AS - Asia 2.022
SA - Sud America 278
AF - Africa 124
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.703
RU - Federazione Russa 1.163
SG - Singapore 920
IT - Italia 419
CN - Cina 324
BR - Brasile 225
HK - Hong Kong 213
VN - Vietnam 207
FR - Francia 127
DE - Germania 123
BD - Bangladesh 111
GB - Regno Unito 111
IE - Irlanda 98
KR - Corea 74
SE - Svezia 69
FI - Finlandia 54
CA - Canada 48
ES - Italia 41
IN - India 33
PL - Polonia 32
NL - Olanda 31
TG - Togo 31
BJ - Benin 29
NG - Nigeria 22
AT - Austria 21
JP - Giappone 20
ID - Indonesia 17
MX - Messico 17
TN - Tunisia 17
AR - Argentina 16
PH - Filippine 13
TR - Turchia 12
IQ - Iraq 11
LT - Lituania 9
PT - Portogallo 9
UA - Ucraina 9
VE - Venezuela 9
BE - Belgio 8
EC - Ecuador 8
TW - Taiwan 8
ZA - Sudafrica 8
CO - Colombia 7
PK - Pakistan 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BH - Bahrain 5
IR - Iran 5
PE - Perù 5
DK - Danimarca 4
DZ - Algeria 4
MA - Marocco 4
PY - Paraguay 4
TH - Thailandia 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
CL - Cile 3
CR - Costa Rica 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
Totale 7.558
Salva come PNG Salva come JPEG
Città #
Singapore 526
Dallas 467
San Jose 451
Ashburn 407
Moscow 376
Chandler 244
Hong Kong 206
Verona 121
The Dalles 97
Dublin 93
Council Bluffs 89
Ho Chi Minh City 77
Beijing 63
Milan 63
Los Angeles 57
Munich 53
Hanoi 49
Buffalo 43
New York 43
London 40
Columbus 33
Lomé 31
Cotonou 29
Seattle 29
Madrid 27
Redondo Beach 26
Helsinki 25
Santa Clara 25
Warsaw 23
Lawrence 22
Princeton 22
São Paulo 22
Rome 21
Abuja 20
Amsterdam 20
Redmond 20
Seoul 19
Boston 18
Sindelfingen 18
Turku 18
Orem 17
Tokyo 17
Frankfurt am Main 16
Montreal 16
Wilmington 16
Paris 15
Vienna 14
Brooklyn 13
Jakarta 13
Toronto 13
Denver 12
Montecchio Maggiore 12
Poplar 12
Haiphong 11
Lappeenranta 10
Tianjin 10
Chennai 9
Chicago 9
Guangzhou 9
Houston 9
Nuremberg 9
Philadelphia 9
Phoenix 9
Atlanta 8
Brussels 8
Da Nang 8
Hải Dương 8
Lisbon 8
Tunis 8
Ancona 7
Ann Arbor 7
Biên Hòa 7
Shenzhen 7
Stockholm 7
Taipei 7
Brasília 6
Pescantina 6
San Francisco 6
Bologna 5
Bonndorf 5
Charlotte 5
Curitiba 5
Des Moines 5
Hyderabad 5
Istanbul 5
Johannesburg 5
Mexico City 5
Ottawa 5
Rio de Janeiro 5
Southend 5
Turin 5
Woodbridge 5
Wroclaw 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Bentivoglio 4
Bexley 4
Can Tho 4
Caracas 4
Totale 4.525
Salva come PNG Salva come JPEG
Nome #
A Comparative Evaluation of the Chemiluminescence Immunoassay and ELISA for the Detection of Islet Autoantibodies in Type 1 Diabetes 249
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 192
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 181
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 168
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 167
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 160
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 157
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 156
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 155
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 147
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 147
Differential diagnosis of lymphocytosis in routine laboratory practice: the contribution of Sysmex- XN9100 141
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 141
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 140
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 138
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 136
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 133
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 131
Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing 130
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 129
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 128
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 128
Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening 125
Improved potassium reliability in whole blood through hemolysis detection on the novel GEM Premier 7000 blood gas analyzer 122
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 119
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 116
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 115
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay 113
Limitations of hemolysis-based correction for potassium measurement in hemolyzed whole blood samples 113
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 113
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 112
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 112
Effect of syringe underfilling on the quality of venous blood gas analysis 112
Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening 112
Monoclonal gammopathy in SARS-CoV-2 infection 110
Cellular immunity against SARS-CoV-2 depends on the serological status 110
Impact of the COVID-19 pandemic on the volume of laboratory testing 108
Evaluating the accuracy of ChatGPT in classifying normal and abnormal blood cell morphology 105
Methadone metabolite (EDDP) crystals in urine: a case report 101
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 101
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 100
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 98
Analytical validation of hemolysis detection on GEM Premier 7000 98
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 98
Assessing Intra- and Inter-Analyzer Imprecision in Automated Hematological Laboratories 95
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 95
Impact of an air bubble within the syringe on test results obtained with a modern blood gas analyzer 94
Evaluation of the acceptability of proposed hemolysis limits for Werfen ACL-TOP 750 CTS 92
Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time 91
Correlation between basal humoral immunogenicity and side effects after receiving the bivalent formulation of a mRNA-based vaccine 89
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 85
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 85
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 81
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 74
Performance assessment of ChatGPT in classification of urine particles 72
Evaluation of freely available artificial intelligence (AI) tools for diagnostic support in a complex clinical and laboratory presentations: a pilot study 70
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 69
Is mixing of blood gas syringes after collection really necessary? 69
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 69
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 68
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease 68
Effect of exogenous lipids contamination on blood gas analysis 67
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 67
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 62
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study 61
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine 58
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations 57
Analytical performance of the Roche Elecsys TnT hs Gen 6 immunoassay 54
Uso de una tira reactiva paraorina en la evaluación de las concentraciones de glucosa y bilirrubina en plasma en entornos con recursos limitados: un estudio de prueba de concepto 50
Evaluation of circadian rhythm of SARS-CoV-2 interferon-gamma release assay (IGRA) in healthy vaccinated individuals: a case-series 50
Intra-and inter-analyzer imprecision of cell population data on Sysmex XN-10 22
Decreased Plasma Concentration of Hydrogen Sulfide in Hospitalized COVID-19 Patients: A Novel Determinant of Mortality? 7
Predicting Iron Deficiencies Using Routine Complete Blood Cell Count Parameters: A Machine Learning Approach and Evaluation 6
Niveles séricos de antígeno prostático específico (PSA) tras vacunación primaria con BNT162b2 5
Impacto de la vacunación primaria con BNT162b2 y una dosis de refuerzo homóloga en los anticuerpos IgA contra SARS-CoV-2 en profesionales sanitarios seronegativos 5
Variación longitudinal comparativa de los anticuerpos totales, IgG e IgA contra el SARS-CoV-2 en receptores de la vacuna BNT162b2 4
Son los anticuerpos IgG e IgM contra los antígenos S y N del SARS-CoV-2 siempre predictores de infección previa por SARS-CoV-2? 3
Totale 7.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.101
article - articoli 27.533
book - libri 0
conference - conferenze 213
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 355
Totale 56.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022205 29 37 7 8 10 4 4 6 14 8 26 52
2022/2023621 36 51 58 116 31 126 23 54 63 9 29 25
2023/2024433 19 30 29 45 66 48 43 71 4 25 38 15
2024/20251.527 65 84 90 185 61 62 64 87 181 139 225 284
2025/20264.901 333 281 405 672 1.139 285 455 285 359 234 225 228
Totale 7.711